Large pericardial effusion with early tamponade physiology requiring pericardiocentesis: a case of Cardiac Tamponade After COVID-19 Vaccination in a prior healthy 18-year-old male who presented with

fever, pleuritic chest pain & shortness of breath 3 weeks after receiving first dose of a COVID-19 mRNA-based vaccine. The patient was found to have a large pericardial effusion with early tamponade

Yasmin Vossoughian, MSNBC reporter?? Any link to Damar?

Background

Hryniewicki et al.

Acute pericarditis is a diffuse inflammation of the pericardial sac with many well-defined etiologies. Acute pericarditis as a vaccine-related adverse event is a rare entity, and the association between pericarditis and the immunogenic response to Coronavirus disease 2019 (COVID-19) vaccines is still being fully characterized.

Case Report

A previously healthy 18-year-old man presented with fever, pleuritic chest pain, and shortness of breath 3 weeks after receiving the first dose of a COVID-19 mRNA-based vaccine. The patient was found to have a large pericardial effusion with early tamponade physiology requiring pericardiocentesis.

Why Should an Emergency Physician Be Aware of This?

As COVID-19 vaccination becomes more prevalent globally, physicians should be aware of pericarditis as a rare but potentially serious adverse reaction. Although a direct causal link cannot be demonstrated, we present this case to increase awareness among emergency physicians of pericarditis as a rare, but potentially serious adverse event associated with COVID-19 vaccination.’

SOURCE:

https://www.jem-journal.com/article/S0736-4679(21)00745-9/fulltext